SCA Pharmaceuticals is recalling 480 syringes of Labetalol HCl injection (20 mg/4 mL) because the product labels show the wrong compounding and expiration dates. The labels incorrectly state a compounding date of 12/27/2018 and a use-by date of 03/27/2019, when the actual compounding date was 12/27/2017 and the correct use-by date was 03/27/2018. This error could lead to the use of medication that is nearly a year past its intended shelf life. Consumers should contact their healthcare provider or pharmacist for guidance regarding any affected syringes.
Using medication past its intended expiration date may result in reduced drug potency or compromised stability, potentially failing to provide the necessary blood pressure management for patients receiving this intravenous treatment.
Contact healthcare provider and return for refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.